Test ID: IGF1
Insulin-Like Growth Factor 1, Serum
Method Description
Describes how the test is performed and provides a method-specific reference
IMMULITE 2000 IGF-1 is a solid-phase, chemiluminescent immunometric assay. First, sample pretreatment is accomplished in an onboard dilution step. Then, patient sample and alkaline phosphatase-conjugated anti-insulin-like growth factor 1 (IGF-1) antibodies are simultaneously incubated with antibody-coated beads. During this time, IGF-1 in the sample forms an antibody sandwich complex that binds to the streptavidin on the beads. Unbound enzyme conjugate is then removed by washing, after which substrate is added. The chemiluminescent substrate, a phosphate ester of adamantyl dioxetane, undergoes hydrolysis in the presence of alkaline phosphatase to yield an unstable intermediate. The continuous production of this intermediate results in the sustained emission of light. The photon output is directly proportional to the concentration of the IGF-1 in the specimen. (Package insert: IMMULITE 2000 IGF-1, Diagnostic ProductsCorporation, Los Angeles, CA PIL2KGF-15, 2008-07-29)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Friday; 5 a.m.-12a.m., Saturday; 6 a.m.-6 p.m.


